Propecia

  • Propecia Medical Record Review & Outsourcing Services

Propecia (finasteride 5mg) manufactured by pharmaceutical giant Merck & Co. was approved by the U.S. Food and Drug Administration (FDA) in 1992 for the treatment of bothersome symptoms in men with benign prostatic hyperplasia (also referred to as BPH or an enlarged prostate), Propecia (finasteride 1 mg) was approved by the FDA in 1997 for use in males only and is indicated for the treatment of male pattern hair loss.

Many men turned to Propecia believing drug makers claims, and gradually their lives changed to the worst, as the foolproof information about the side effects of the drugs were not shared by the manufacturers.

It is observed that even after Propecia is discontinued, the complications do not recover.

Serious Alleged Injuries may include:

  • High-grade prostate cancer
  • Erectile dysfunction
  • Ejaculation disorder
  • Reduced sexual sensation
  • Diminished or reduced libido
  • Infertility
  • Genital shrinkage
  • Cognitive impairment
  • Depression

FDA SAFETY WARNINGS:

In June 2011, it was evidenced that Propecia increases the risk of prostate cancer, the FDA announced new labeling requirements.

There was another change announced for Propecia in April 2012, which suggested that label should include warnings about libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug.

Lawsuit Allegations:

Many sexual dysfunction cases against Propecia were pending, which were centralized to Eastern District Court of New York on April 16, 2012. These cases were consolidated into MDL 2331, a multidistrict litigation led by U.S. District Judge John Gleeson, which has grown to more than 1,000 lawsuits.

In October 2016, a judge selected four bellwether cases. A huge number of cases are pending in New Jersey state courts. The first bellwether was scheduled to go to trial in September 2017.

In addition to the MDL lawsuits, there are about 300 Propecia erectile dysfunction lawsuits filed in the state courts across the country.

Evidences:

  • Usage in Pharmacy Records
  • Indication of usage in Medical Records
  • Complication and treatment after usage
  • Persistent sexual dysfunction

Medical Record Review and claim validation of Propecia case should take approximately 3 hours in most instances; however, this approximation may vary in cases based on the volume of records.

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

Thanksgiving 2018 Celebration at Neural IT
Thanksgiving 2018 was celebrated at Neural IT with a bash to express appreciation for each other
October 20, 2018, Picnic to the Water Kingdom
October 20, 2018, Picnic to the Water Kingdom turned out to be the most exciting and fun-filled d
A Click with Peyton Manning at MTMP Fall Conference 2018
A Click with Peyton Manning at MTMP Fall Conference 2018.

Latest Tweets